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Abstract
The challenge was always great for lipophilic photosensitizer use in the photo-
dynamic therapy (PDT) for treatment of internal body diseases. Photosensitizer 
metabolism in liver, incompatibility of the molecules in the gastric acid, aggregation 
in the bloodstream, opsonization of molecules and phagocyting process hamper 
the application of the free lipophilic photosensitizer in disease treatment using 
PDT. This problem has been partially resolved using the drug delivery system to 
encapsulate the photosensitizer. Many studies have been reported using polymeric 
nanoparticles to encapsulate the lipophilic photosensitizer showing excellent results 
for PDT, but few nanoparticulate formulations are available at the pharmacies. The 
absence of deep knowledge about the influence of synergic effect of parameters 
used in the nanoparticle preparation on its properties, the photobleaching process 
of encapsulated photosensitizer and the molecule aggregation into the nanoparticle 
can decrease the photodynamic efficacy for the lipophilic photosensitizer. Our 
research group has studied the influence of many parameters on the nanoparticu-
late properties of several encapsulated phthalocyanines and porphyrin using facto-
rial design, evaluating the free and encapsulated compound aggregation, efficacy 
to reduce the viability of cancer cells, the photooxidation of the biomolecules and 
the influence of photobleaching. This work shows the most important results to be 
consider in the optimization of the polymeric nanoparticle.
Keywords: polymeric nanoparticle, factorial design, phthalocyanine, porphyrin, 
photodynamic therapy, photooxidation, cancer cells, photobleaching
1. Introduction
Photodynamic therapy (PDT) is an important therapeutic modality used in 
the treatment of cancer and several non-malignant diseases, including infections 
and dental treatments [1–5]. It is characterized by the administration of a photo-
sensitizer (PS), a light source to activate it and oxygen molecules (Figure 1) [6]. 
After administration of the photosensitizer, the diseased tissue is irradiated with 
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visible light, causing the excitation of the PS to a singlet electronic state (S1), 
which can be deactivated to the fundamental state (S0) through radiative pro-
cesses (fluorescence or phosphorescence) or non-radioactive (internal conver-
sion, intersystem crossing or vibrational relaxation). Among these processes, 
intersystem crossing is essential for PDT. It consists of a prohibited transition by 
spin from the excited singlet electronic state (S1) to the excited triplet state (T1). 
In this state, the PS can interact with oxygen molecules or other biomolecules 
that are present in the irradiated tissue generating reactive oxygen species (ROS) 
that can cause damage to diseased tissues [7, 8]. These ROS can be generated by 
two mechanisms, [9] involving energy transfer (type II mechanism) or electron 
transfer (type I mechanism) (Figure 1).
The success of the treatment, fundamentally, depends on the photochemical, 
photobiological and pharmacokinetic properties of the photosensitizer. New 
porphyrin and phthalocyanine derivatives have been synthesized and encap-
sulated because their photochemical properties are suitable for PDT [10–12]. 
In general, hydrophobic photosensitizers tend to form aggregates in aqueous 
medium, affecting their bioavailability and their ability to generate reactive oxy-
gen species, [13] and consequently, reducing their efficacy in treatment by PDT. 
In addition, lipophilic molecules hamper the administration of photosensitizer 
by parenteral via [14]. The nanocarrier systems has proven to be quite effective 
to solve this problem since they facilitate the administration of the hydrophobic 
photosensitizer, protect the photosensitizer from aggressive environments and 
decreasing its aggregation state [15].
Many studies show prominent results with polymeric nanoparticles as carriers 
of lipophilic photosensitizers due to the benefits associated with their application in 
PDT for cancer treatment [16–18] such as effectively increase in the amount of PS 
in the target tissue due to a greater volume/area ratio; prevent the premature release 
of the photosensitizer, avoiding its accumulation in healthy tissues; maintaining 
drug concentration at therapeutically appropriate intervals in blood circulation and 
tissues; greater ability to penetrate the target tissue due to its size; in addition to 
protecting drugs from liver inactivation and enzymatic degradation [15].
Figure 1. 
PDT mechanism involving the combination of a photosensitizer, a light source and oxygen molecules. After 
excitation to a higher energy state (1), the photosensitizer may suffer rotovibrational decays to the excited state 
S1 (2), from which the photosensitizer can suffer energy decay to the fundamental state S0, via fluorescence (3), 
intersystem crossing (4) or phosphorescence (5).
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Another advantage of polymeric nanoparticles is their biocompatibility and 
biodegradability, once it is degraded by enzymatic processes that generates non-
toxic and biocompatible products, being removed from the body by physiological 
pathways. An example is the nanoparticle of poly(lactide-co-glycolide) (PLGA), a 
polymer approved by the Food and Drug Administration (FDA) and that we used 
in our research [15]. However, it also be reported that the use of nanomaterials in 
contemporary clinical practice need to be monitored because of the unpredicted 
effects of the cumulative exposes of non-biodegradable nanoparticle in the 
human body [19].
Few nanoparticulate formulations are on the shelves of pharmacies due to the 
lack of knowledge of the combinatorial influence of the parameters used in the 
preparation of the nanoparticles on the fundamental properties for maximum 
therapeutic potential, [5] a fact that hampers the scale up process for the produc-
tion of nanoparticulate formulations. Besides, the poor batch-to batch reproduc-
ibility to prepare polymeric nanoparticle, the low solubility of some polymers in 
water that requires the use of organic solvent to synthesize the nanoparticle, the 
low glass transition temperature of some polymers that limit the use of them to 
prepare the nanoparticulate formulation and the high cost of biodegradable poly-
mers are drawback that hamper the development of nanoparticulate pharmaceutic 
formulation for using in PDT. For these reasons, we have studied the influence of 
the parameters involved in the preparation of polymeric nanoparticle loaded with 
several porphyrin and phthalocyanine derivatives (Figures 2-4) that have different 
physicochemical properties (Table 1).
Given these considerations, we present an overview of the main results obtained 
by our research group on the influence of several preparation parameters on 
the final properties of polymeric nanoparticles loaded with photosensitizers for 
Figure 2. 
Molecular structures optimized by Avogadro and MOPAC software for (A) gallium phthalocyanine chlorine 
(GaPc), (B) indium phthalocyanine chlorine (InPc) and (C) chloro(5,10,15,20-tetraphenylporphyrinato) 
indium (III) (InTPP).
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application in PDT, besides regarding the effect of encapsulation in reducing the 
photobleaching process of photosensitizer and on the efficiency of nanoparticles 
containing photosensitive compounds in reducing the viability of cancer cells or in 
biomolecules photooxidation.
Figure 3. 
Molecular structures optimized by Avogadro and MOPAC software for (A) 5-hexyl-10,20-bi(3-hydroxyphenyl)
porphyrin (hex-m-bisHPP), (B) 5-hexyl-10,15,20-tri(3-hydroxyphenyl)porphyrin (hex-m-trisHPP) and (C) 
5,10,15,20-tetra(3-hydroxyphenyl)porphyrin (m-THPP).
Figure 4. 
Molecular structures optimized by Avogadro and MOPAC software for 1,4-(tetrakis[4-(benzyloxy)phenoxy] 

































Compound GaPc InPc InTPP m-THPP Hex-m-BisHPP Hex-m-TrisHPP InTBPPc
Heat of Formation / kj/mol § 867.59016 866.26780 912.86350 418.11873 569.44802 412.25908 545.82102
Volume / Å3 § 596.57 606.78 782.35 781.06 691.12 799.51 1555.32
Ionization Potential / EV § 7.304876 7.272500 7.860061 8.012104 7.779898 7.811042 7.160890
Energy Difference HOMO-LUMO / EV § 4.862 4.903 5.965 6.185 5.969 6.106 4.922
Dipole Moment / D § 7.00151 7.40825 4.43138 3.91867 2.74405 1.76290 8.27066
Log P* 4.52 1.67 2.33 6.82 6.78 7.57 9.17
Log S* −4.04 −4.59 −6.12 −5.23 −5.10 −5.33 −6.52
Polarizability** 66.75 67.90 90.90 87.68 75.43 87.05 157.27
HLB** 4.20 4.50 3.40 3.22 3.20 3.05 7.63
*Values were calculated from ALOGPS 2.1 Program http://www.vcclab.org/lab/alogps/
**Values were calculated from MarvinSketch 20.16 Program.
§Values were calculated from MOPAC 2016 Program.
Table 1. 
Physicochemical properties of the studied photosensitizers.
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2.  Influence of nanoparticles preparation parameters on their final 
properties
The development of carrier systems involves a lot of study of the variables used in 
the formulations preparation and their influences on the nanoparticulate properties 
that reflect on the cellular uptake of nanoparticles, its bioavailability and, conse-
quently, the photodynamic efficiency. The approach to analyze the individual effect 
and the combinatorial effect (synergistic or antagonistic) of the parameters is usually 
done by factorial design of experiments, which all levels (experimental domains) of a 
factor are combined with all levels of the other factors of the experiment [16].
The influence of factors on the characteristics of nanoparticles is intrinsically 
linked to the production process [16, 20, 21]. Many works have shown the indi-
vidual effects of some parameters involved in the nanoparticles preparation stage 
on their properties. However, the influence of a parameter used in a polymeric 
nanoparticles formulation will not always produce the same response for similar 
formulations [5].
There are significant challenges to consolidate polymeric nanoformulations in the 
pharmaceutical market since small changes in the composition of the formulation, for 
example, the encapsulated drug, can influence the nanoparticles properties, such as 
the particle size, the surface charge, the residual amount of emulsifier on the surface 
of the particles, and encapsulation and recovery efficiencies of the nanoparticles [5].
2.1 Size
The particle size used for the treatment of oncological and non-oncological 
diseases depends on the administration route and/or the type of diseased tissue. For 
example, in intravenous administration, the particles must be smaller than 5 μm in 
order to circulate through the capillaries, however, smaller sizes are necessary for 
nanoparticles reach the tumor vessels and remain longer in the blood stream [5, 8, 22].
Researches have shown that nanoparticles with sizes smaller than 200 nm have 
a longer circulation time in the bloodstream due to the reduction of the recognition 
of the nanoparticle by plasma proteins (opsonin) that signal the reticuloendothelial 
system to act in the phagocytosis process of the nanoparticles. Remaining longer in 
the circulatory system, smaller diameter particles could interact more effectively 
with cell membranes, presenting greater capacity of cellular internalization due to 
the overexpression of porous in tumor cells membranes, a fact that would result 
in greater efficiency of nanoparticulate photosensitizers in reducing cell viability 
through PDT [5, 8, 22].
A highly significant parameter in causing changes in the nanoparticles size was 
the stirring rate used in the preparation process. The increase of stirring rate leads 
to smaller sized nanoparticles due to the better dispersion of the organic phase 
in the aqueous phase, reducing the droplet size of the organic phase and, conse-
quently, the nanoparticle size [20].
Although the stirring rate is considered the main factor responsible for the size 
reduction of the nanoparticle, in some formulations this parameter is not significant 
[23]. In the preparation of PLGA-PEG nanoparticles loaded with chloro(5,10,15,20-
tetraphenylporphyranato) indium(III) (InTPP – Figure 2C), the ethanol percent-
age in the aqueous phase was the main parameter responsible for size decrease, not 
the stirring rate [20].
Our group demonstrated that the individual increasing in the ethanol percent-
age in the aqueous and organic phases contribute to reduce the nanoparticles size. 
The ethanol present in the aqueous phase causes an increase in viscosity while the 
addition of ethanol in the organic phase accelerates the separation of phases from 
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the PLGA during the dispersion of the organic phase in the aqueous phase. These 
effects hinder the coalescence of organic droplets dispersed in the aqueous phase, 
preventing an increase in the nanoparticles size [16, 20].
Analyzing two preparation methods, the PLGA-PEG nanoparticles loaded 
with gallium phthalocyanine (GaPc - Figure 2A) prepared by the Emulsification-
Diffusion Method (EDM) were smaller in size than the nanoparticles prepared by 
the Emulsification-Evaporation Method (EEM). In the EDM method, the organic 
solvent is dispersed in the aqueous phase generating droplets that are stabilized 
by colloidal stabilizing agents, however, the rapid efflux of solvent can cause the 
formation of aggregates and a population with varying sizes [5].
The aqueous phase temperature is another factor that can positively or nega-
tively influence the nanoparticles size. The increase in temperature reduces the 
viscosity of the mixture between the organic phase and the aqueous phase, favoring 
the coalescence of organic solvent drops and consequently increasing the particles 
size, but the increase in temperature also favors the diffusion of the organic solvent 
into the aqueous phase, favoring the reduction of particle size. In the EDM method 
the effect of coalescence is more pronounced, causing the size increase, while in 
the EEM method the diffusion of the organic solvent to the aqueous phase is more 
pronounced, decreasing the nanoparticle size [5].
Combinatory effects of two parameters can also be significant for nanoparticle 
size. The binary effect between changing the method from EEM to EDM and 
increasing the aqueous phase temperature tends to increase the nanoparticles size 
[5]. Univariate methods do not allow to identify the combinatory effect that could 
be important for a determinate nanoparticulate property being necessary the use of 
factorial design.
The ratio between the photosensitizer mass and the polymer mass is also a 
parameter that can influence the nanoparticle size. In the study of the preparation 
of PLGA nanoparticles loaded with three porphyrins (Hex-m-bis-HPP, Hex-m-tris-
HPP and m-THPP - Figure 3A-C, respectively) with different amphiphilicities, [16] 
the effect of the porphyrin/polymer mass ratio on the nanoparticle size was only 
significant in m-THPP nanoparticles, which the increase in the mass ratio caused a 
reduction in size. The low polymer concentration reduces the organic phase viscous 
resistance against the shear force during the emulsification process, favoring the 
reduction of the organic phase droplets size dispersed in the aqueous phase and, 
consequently, reducing the nanoparticles size [16].
Different results have also been reported in the literature, not observing any 
effect of the photosensitizer mass/polymer mass ratio on the PLGA nanoparticles 
size loaded with bupivacaine [24], while others have reported that an increase in the 
proportion decreased the nanoparticles size [25, 26].
Another parameter that can also influence the nanoparticles size is the polyvinyl 
alcohol (PVA) concentration, which is the most used emulsifier in formulations 
preparation stage. In some cases, the effect of increasing the PVA concentration on 
the particle size may be very similar to the effect of the stirring rate. It is known that 
PVA molecules anchor in the aqueous/organic interface formed during emulsifica-
tion, causing a decrease in interfacial tension and favoring the mechanical and 
spatial stabilizations of the organic droplets dispersed in the aqueous phase [27]. 
In addition, polymeric PVA chains not anchored to the nanosphere surface can 
increase the aqueous phase viscosity. The reduction in interfacial tension and the 
increase in viscosity caused by PVA favor a decrease in the nanosphere size [20].
Emulsification time is a factor that may or may not be significant on size. In the 
preparation of PLGA-PEG nanoparticles containing gallium phthalocyanine, this 
parameter did not significantly influence the nanoparticles size [5], however some 
studies have already shown that it can increase or decrease the size [28]. As stated 
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earlier, each parameter behaves in a particular way according to the parameters used 
in the preparation of nanoparticles. All these influences on size were summarized in 
Figure 5.
Besides the preparation parameters, the physicochemical properties of pho-
tosensitizers can also influence nanoparticles size. The polymeric PLGA-PEG 
nanoparticles loaded with GaPc or InTBPPc had different results for size distribu-
tion. The average diameter of the InTBPPc nanoparticles was 1.3 times greater than 
for nanoparticles with GaPc. According to the optimized structures designed by 
the molecular modeling program (Figure 2A and 4), it was shown that InTBPPc 
has a volume of 1555.32 Å3 (Table 1), that is 2.6 times greater than GaPc. This result 
suggests that the molecular size of the encapsulated phthalocyanine may influence 
the increase in the size distribution and the nanoparticles diameter [29].
The storage of lyophilized samples at certain temperatures is another factor 
that can influence the particles size. Studies were conducted with the PLGA-PEG 
nanoparticles loaded with GaPc (Figure 6) to evaluate the influence of the for-
mulation storage at different temperatures on the nanoparticles size. The experi-
ments were carried out with a formulation characterized by presenting 88.9% of 
the nanoparticles with a diameter smaller than 199.9 nm, an important outcome 
since particles smaller than 200 nm remain longer in the circulatory system [5]. 
The experiments suggest that the temperature of 20°C is more suitable for storage 
purposes of the formulations for 4 weeks, due to the results of less variation in the 
average diameter of the particles. Even considering the statistical variation of the 
measurements, there are changes in the PLGA-PEG nanoparticles size that may be 
associated with the aggregation of the particles during the storage period and the 
difficulty of disintegrating them during the process of redispersion in water. Such 
average size variations were greater for lower or higher temperatures than 20°C.
Similar analysis was performed with lyophilized formulations of PLGA-PEG 
nanoparticulate loaded with InTBPPc (Figure 7) for only 12 days at temperatures 
of 5°C and 35°C. Before the storage process, the formulation was characterized 
with a population of 98.9% of the particles with an average diameter smaller than 
199.9 nm. In the short storage period, the generation of small and large aggregates 
Figure 5. 
Effects of some parameters involved in the nanoparticles preparation stage [(A) stirring rate, (B) PVA 
concentration, (C) ethanol concentration in the aqueous phase, (D) ethanol concentration in the organic 
phase, (E) emulsification time, (F) changing the preparation method from EEM to EDM, (G) aqueous phase 
temperature, (H) photosensitizer mass/polymer mass ratio] over different nanoparticulate properties [(RC) 
residual chloroform, (EE) entrapment efficiency, (RE) recovery efficiency, (PVAr) residual PVA, size, (ZP) 
zeta potential].
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was observed at temperatures of 5°C and 35°C, with the size variation being greater 
for the temperature of 35°C in the first 8 days. This temperature is above the 
PLGA-PEG glass transition temperature (Tg at 30°C), [30] a fact that favors particle 
aggregation. Therefore, it can be concluded that storage temperatures, whether 
low or high, can influence the formation of aggregates, a fact that could reduce the 
photosensitizer efficiency during PDT.
Figure 6. 
Average diameter of the PLGA-PEG nanoparticle loaded with GaPc after storage for 1–4 weeks in different 
temperatures.
Figure 7. 
Average diameter of the PLGA-PEG nanoparticle loaded with InTBPPc after storage for 12 days in different 
temperatures.
Photodynamic Therapy - From Basic Science to Clinical Research
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2.2 Zeta potential
The zeta potential is a property related to the particles physical stability that can 
be used to measure the magnitude of the repulsion or attraction. The maximiza-
tion of the repulsive forces between the nanoparticles, minimizes the interactions 
responsible for colloidal instability, consequently interfering in the photodynamic 
efficacy of an encapsulated photosensitizer [5, 20].
Nanoparticles coated with amphiphilic polymers, such as PEG, usually have a 
higher zeta potential due to the increase in the contact surface and, consequently, 
to the shielding of the nanoparticle surface charge [31–34]. Therefore, the greater 
surface area (ratio of surface area/volume) of the nanoparticle, the greater is the 
residual PVA percentage at the nanoparticle interface and, consequently, the greater 
is the zeta potential value [5].
Thus, it is expected the parameters that influence the nanoparticles size will also 
be significant on the zeta potential values. As the stirring rate is one of the main 
factors in causing the decrease of the nanoparticles size, it will also be expected that 
this factor is able to affect the zeta potential, increasing its value [20].
GaPc-loaded PLGA-PEG nanoparticles presented higher zeta potential values 
when prepared by EDM than those prepared by the EEM. This fact corroborates 
with the results obtained from the nanoparticle prepared by the EEM, which 
presented greater sizes and smaller values of zeta potential, suggesting that they are 
more stable from an electrostatic point of view [5].
The increase in the aqueous phase temperature also caused a significant decrease 
in the absolute value of the zeta potential, because this factor induced an increase 
in the nanoparticles size which have less residual PVA adsorbed on their surfaces, 
resulting in a smaller zeta potential [5].
In the preparation of PLGA nanoparticles containing three porphyrins (m-THPP, 
Hex-m-bisHPP and Hex-m-trisHPP) with different amphiphilicities, each formula-
tion presented a different response of the preparation parameters related to the 
zeta potential, with results intrinsically linked to particle size. For Hex-m-bisHPP-
loaded nanoparticles, the increase in the ethanol percentage in the aqueous phase 
caused an increase in the zeta potential due to the decrease of the nanoparticle size. 
While for nanoparticles containing m-THPP, the porphyrin/polymer mass ratio was 
the only significant factor that caused an increase in the zeta potential value since 
this factor decreased the particle size [16]. The summary of all influences on the 
zeta potential was indicated in Figure 5.
2.3 Entrapment efficiency
The entrapment efficiency relates the amount of drug that was effectively 
encapsulated/adsorbed on the nanoparticle. This property depends on the physi-
cochemical properties and the interaction between the photosensitizer, the carrier 
matrix and the surrounding environment. Studies have shown that higher entrap-
ment efficiency is associated with better photodynamic efficiencies for a short 
period of light activation [19, 35].
The diffusion process of the photosensitizer from the organic phase to the 
aqueous phase has significantly influenced the substance entrapment efficiency 
during the nanoparticle preparation process. Results have shown that the individual 
increase in the PVA concentration and the ethanol concentration in the aqueous 
phase tend to increase the photosensitizer encapsulation. The aqueous phase viscos-
ity increases with the PVA and ethanol concentrations, which favors the formation 
of smaller sizes nanoparticles, having a specific surface area (area/volume) that 
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allows a greater number of PVA molecules at the interface of the organic/aqueous 
phase. This hinders the diffusion of photosensitizers from the organic phase to the 
aqueous phase, favoring an increase in nanoparticle encapsulation. On the other 
hand, the combinatory effect caused by the simultaneous increase in the concentra-
tion of PVA and ethanol in the aqueous phase decreases the entrapment efficiency 
of InTPP in PLGA nanoparticles, as experiments showed that PVA and ethanol 
favor the solubilization of InTPP in aqueous medium [20].
When the method is changed from EEM to EDM, the entrapment efficiency 
decreases since the EDM method favors the formation of smaller diameter nanopar-
ticles, facilitating the organic solvent diffusion into the aqueous phase and decreas-
ing the entrapment efficiency of the photosensitizer in nanoparticles [5].
The increase of the aqueous phase temperature combine with the change in the 
preparation method also influences the photosensitizer entrapment efficiency. In 
the EEM method, the increase in the aqueous phase temperature causes the more 
effectively evaporation of the organic solvent, leading to fast polymer coacervation 
and, consequently, the organic/aqueous interface solidification. This increases the 
photosensitizer entrapment efficiency in the PLGA-PEG nanoparticles prepared 
by EEM. In the EDM method, the same increase in the aqueous phase temperature 
favors the solvent diffusion from the organic phase to the aqueous phase that 
carries the photosensitizer out of the nanoparticle, decreasing the entrapment 
efficiency [5]. All effects of parameters on entrapment efficiency were registered 
in Figure 5.
In addition to the parameters used in the nanoparticle preparation, the 
physicochemical properties of the photosensitizer may interfere on the entrap-
ment efficiency. As an example, molecules of greater polarity tend to diffuse 
more easily from the organic phase to the aqueous phase, decreasing the entrap-
ment efficiency [16]. The theoretical calculations compared to experimental 
results have suggested that photosensitizers with higher volume tend to be 
less efficiently encapsulated by nanoparticles. This was observed for InTBPPc 
molecules and also for Hex-m-TrisHPP molecules (Table 1). Molecules that have 
close volume values have shown similar entrapment efficiency as GaPc and InPc 
(Figure 2A, B, respectively).
2.4 Recovery efficiency
The recovery efficiency calculates the percentage of nanoparticle that has been 
produced and recovered. It is a property that has economic importance and has 
great value for the pharmaceutical industries, since they aim to reduce the produc-
tion costs of the nanoparticulate formulation.
The nanoparticles size influences directly the recovery efficiency. Smaller 
nanoparticles are expected to be less recovered during the washing step than larger 
nanoparticles since the sedimentation rate of the particles in a centrifugal field is 
proportional to the square particle diameter. Thus, the parameters that influence 
the nanoparticles size tend to influence the recovery efficiency [20].
Parameters that cause a reduction in size, such as stirring rate, the EDM prepara-
tion method, the ethanol concentration in the aqueous or organic phase, as well as 
the emulsification time can favor the decrease of the recovery efficiency [5, 20].
Synergistic effects can be significant for recovery efficiency. For example, increas-
ing the aqueous phase temperature together with the change in the preparation 
method, or increasing the emulsification time together with the change from the EEM 
method to EDM, can increase the recovery efficiency [5]. All effects of the parameters 
used to prepare of nanoparticles on the recovery efficiency are shown in Figure 5.
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2.5 Residual polyvinyl alcohol (PVA)
PVA is the emulsifier most commonly used in the polymeric nanoparticles 
preparation. Even with the washing steps during the process, aiming to reduce the 
excess of PVA, an amount of these molecules remains adsorbed to the nanoparticle 
polymeric matrix due to the orientation of the PVA hydrophobic part in the organic 
phase, keeping molecules attach on the surface of the particle after the coacerva-
tion process [31]. This residual PVA on the particles surface can interfere on the 
nanoparticles physicochemical and biological properties, such as the size, release 
profiles of encapsulated drugs and intracellular uptake of the nanoparticles.
PVA tends to be adsorbed on the nanoparticle surface through the hydrophobic 
part of vinyl acetate, which tends to anchor the polymer in the aqueous/organic 
interface formed during the emulsification process. Smaller sized particles have 
a greater specific surface area, so it requires a greater amount of PVA to stabilize 
the emulsion droplets. Thus, these nanoparticles retain a greater amount of PVA 
adsorbed on its surface. Therefore, parameters that influenced the particle size, 
tend to affect the percentage of residual PVA [5, 16, 20, 22].
As the ethanol in the aqueous phase and the stirring rate favor the preparation 
of smaller nanoparticles, it is expected a higher amount of residual PVA on the 
small nanoparticle surface. However, the relation between the nanoparticles size 
and residual PVA is not immutable. An example is the PLGA-PEG nanoparticles 
containing gallium phthalocyanine [20]. It was reported that the aqueous phase 
temperature increased the nanoparticles size and the residual PVA while the change 
in the preparation method from EEM to EDM decreased the nanoparticles size and 
the residual PVA. Therefore, a different situation that it was expected. Probably, the 
presence of PEG linked to PLGA hindered the interactions of PVA molecules with 
the organic/aqueous interface [20].
Residual PVA can also be influenced by synergistic effects. For example, 
changing the preparation method from EEM to EDM, associated with an increase 
in the aqueous phase temperature can cause an increase in the residual PVA. 
However, the increase of the emulsification time together with the change of 
the preparation method can reduce the residual PVA [5]. All influences of the 
parameters used in the preparation of polymeric nanoparticle were summarized 
in the Figure 5.
It should be noted that the residual PVA values can still vary according to the num-
ber of washing steps and the method used to wash the nanoparticle suspension [5, 22].
2.6 Residual chloroform
The organic solvent can be retained by nanoparticles during the preparation of the  
nanoparticulate formulation, becoming a residual organic impurity. Therefore, the 
quantification of solvent residual is necessary to eliminate toxicological risks for 
patients. According to the American Pharmacopeia, the residual chloroform limit 
is 60 ppm for pharmaceutical formulations. Thus, it is very important to evaluate 
the influence of the factors involved in the nanoparticle preparation on the residual 
chloroform concentration [20].
The percentage of residual chloroform, as described for other properties, is also 
related to the nanoparticle size. Thus, there is a tendency to reduce residual chloro-
form linked to the reduction in the nanoparticles size.
In the preparation of PLGA-PEG nanoparticles containing chloro(5,10,15,20-
tetraphenylporphyranato) indium(III) (InTPP - Figure 2C), the influence of four 
parameters on the residual chloroform percentage was studied: PVA concentration, 
stirring rate, ethanol percentage in the aqueous phase and in the organic phase [20].
13
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The stirring rate and the ethanol percentage in the aqueous phase were the 
factors that significantly influenced the residual solvent, favoring the decrease 
of residual chloroform. The increase in the stirring rate favors the organic phase 
dispersion into the aqueous phase, generating small organic droplets that favor the 
fast solvent diffusion into the aqueous phase. On the other hand, ethanol in the 
aqueous phase hinders the coalescence of organic droplets dispersed in the aqueous 
phase, favoring the formation of smaller diameter particles [20].
Although the individual effects of ethanol in the aqueous phase and the increase 
in stirring rate cause a decrease in residual chloroform, the synergistic effect of the 
simultaneous increase of these factors caused an increase in residual chloroform. 
Both factors favored the decrease in the nanoparticles size. Small size nanoparticles 
tend to present a higher residual PVA percentage on the particles surface, which 
makes difficult the solvent diffusion from organic droplets into the aqueous phase. 
This diffusion becomes even more difficult after the solidification of the polymeric 
matrix surface layer during the process of evaporation of the organic solvent, favor-
ing the residual increase of chloroform in the nanoparticles [20]. All influences on 
residual chloroform have been reported in Figure 5.
3. Photobleaching
Experimental results have shown that the photobleaching process can hinder the 
photodynamic efficiency of photosensitive compounds [36, 37]. Photodegradation 
of photosensitizers can reduce the concentration of these photoactive compounds in 
diseased tissue, decreasing the efficacy of PDT to reduce cell viability, leading to an 
incomplete treatment. On the other hand, photobleaching can reduce the photosen-
sitivity of healthy tissues after irradiation due to the lower amount of reactive oxy-
gen species generated in the photodynamic process motivated by the destruction of 
photosensitizer molecules. Considering that phthalocyanines are photosensitizers 
that tend to suffer photobleaching, [37] as well as to aggregate in aqueous medium, 
our group evaluated the ability of polymeric nanoparticles to reduce the aggregation 
of these lipophilic molecules and also the effect of photobleaching [29].
The laser power and the concentration of free phthalocyanine significantly 
influenced the photobleaching for concentrations in which the molecule is in the 
monomeric state since the photosensitizer aggregation state tends to decrease the 
photobleaching process due to the difficulty to produce reactive oxygen species [29].
Works have shown that the encapsulation of photosensitizers decrease the effect 
of photobleaching in phthalocyanines when compared to free molecules due to the 
scattering of light caused by the polymeric matrix [5, 7, 8, 29]. More soluble photo-
sensitizers tend to be more susceptible to suffer photobleaching and even encapsu-
lated can be photodegraded according to the laser power and irradiation dose used, 
limiting its ability to be used as a good photosensitizer in photodynamic therapy 
[29]. The short storage period at several temperatures did not cause significant influ-
ence in the photobleaching behave of the encapsulated phthalocyanines, probably 
due to the aggregation process of the particles (Figures 6, 7) (results not showed).
4. Photooxidation
Phthalocyanines are a class of compounds used as photosensitizers due to their 
chemical, electronic and spectroscopic properties, [38, 39] in particular, due to the 
intense absorption of these compounds in the therapeutic window and their ability 
to generate singlet oxygen in the presence of a light source.
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Researchers have shown that the presence of heavy atom in the phthalocyanine 
structure favors the generation of singlet oxygen due to the increase in spin-orbital 
coupling and, consequently, the transition of the photosensitizer from an excited 
singlet state to a triplet state (intersystem crossing) [40–42]. In addition, the 
literature suggests that photooxidative mechanisms for singlet oxygen are usually 
more efficient due to their greater diffusibility and higher reaction rate constants 
with substrates [43, 44]. However, the metallophthalocyanines present limited 
solubility in certain solvents due to the symmetry of molecular structure, hamper 
their application in PDT [29].
The chemical structure of phthalocyanines has been modified by introducing 
substitutes in the peripheral or non-peripheral positions of the phthalocyanine 
nucleus to reduce the molecule symmetry and consequently increase the polarity 
and solubility of the phthalocyanines [41, 42]. Besides, studies show that encap-
sulation improves the photodynamic efficiency of the photosensitizer, as well as 
decreases side effects such as photosensitivity of the skin after photodynamic treat-
ment, and reduces molecular aggregation compared to phthalocyanines dissolved in 
aqueous medium [5, 7, 8, 29, 45].
We have studied the photodynamic efficiency of different porphyrins and phtha-
locyanines encapsulated in polymeric nanoparticles (Figures 2-4). As an example, 
gallium phthalocyanine (GaPc - Figure 2A) and 1,4-(tetrakis[4-(benzyloxy)
phenoxy] phthalocyaninato) indium(III) chloride (InTBPPc - Figure 4) are conve-
nient photosensitizers for PDT. These compounds have high singlet oxygen (0.41 and 
0.94, respectively) and triplet (0.69 and 0.97, respectively) quantum yield. However, 
InTBPPc has more interesting features for use in PDT [29].
The photooxidation of simple molecules (as dimethylanthracene (DMA) and 
tryptophan (Trp)) was used to evaluate the photodynamic efficiency of each free 
and encapsulated phthalocyanines. It is notable that the asymmetry caused by 
(benzyloxy)phenoxy group in phthalocyanine seems to increase the photodegrada-
tion of InTBPPc, due to the greater solubility of the photosensitizer which favors 
the reduction of its aggregation state. The decrease in the aggregation state favors 
the generation of singlet oxygen and consequently, the efficacy of the free photo-
sensitizer in photooxidizing simple molecules such as DMA and Trp, as well as the 
phthalocyanine photobleaching [29]. Therefore, free InTBPPc was more efficient 
than free GaPc in photooxidate DMA and Trp molecules, due to its lower aggrega-
tion state and the higher capacity of free InTBPPc to generate singlet oxygen. 
However, the encapsulated GaPc proved to be more efficient than the encapsulated 
InTBPPc in photooxidate the Trp molecules, corroborating that the encapsulation 
can enhance the photosensitizer photocytotoxicity and reduce the aggregation state 
of the free photosensitizer [29].
We have demonstrated that the photocytotoxicity of encapsulated photosen-
sitizers depends on the incubation time, the photosensitizer concentration and 
the laser power [5, 7, 8, 16, 29]. However, these observations cannot be considered 
a fact for all free or encapsulated photosensitizers due to their solubility charac-
teristics, their states of aggregation and the influences of the parameters used in 
the nanoparticles preparation on the nanoparticulate properties. For example, 
the aggregation state of free InPc decreases the photodynamic efficiency of this 
photosensitizer, so that the viability of tumor cells is not altered by increasing the 
concentration and laser power [7].
We have observed that each nanoparticulate formulation should be treated in 
a particular way, taking care to do generalizations about certain conclusions as 
susceptible to be applied to all formations. An example was the result observed 
with InTBPPc, the encapsulation process did not increase its efficiency in the 
photooxidation process of Trp due to the photobleaching process suffered by the 
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photosensitizer [29]. In general, the encapsulation process of photosensitizers has 
not created barriers for the singlet oxygen generation, and has increased the uptake 
of photosensitizer into the cancer cells, improving the efficiency of the phthalocya-
nines and porphyrins to reduce the viability of cancer cells [7, 8, 16].
It was also shown that the photocytotoxic activity of nanoparticles loaded with 
porphyrins did not depend on the different amphiphilic characteristics of the 
compounds, probably due to the encapsulation process [16]. Even the similarities in 
photodynamic efficacy are related to the degree of similarity in the internalization 
of each encapsulated photosensitizer inside tumor cells [16].
5. Future perspectives and challenges
The greatest challenge when it comes to oncology is prepared drugs with high 
specificity to promote the death of malignant cells without harming healthy ones. 
PDT has been used with successful to treat several cases of cancer with a lesser 
side effects than those treated by conventional chemotherapy. New photosensitiz-
ers have been synthesized to increase the photodynamic efficiency on the disease 
tissues and to facilitate the photosensitizer administration during the treatment. 
However, the hydrophobicity of new compounds should not limit their use in PDT. 
The use of nanoparticles as carrier has motivated the research in PDT since results 
had showed very promising advances in reducing the viability of the cancer cells 
due to the specificity achieved by the targeted or magnetic drug delivery system 
and due to the increase of the bioavailability of the nanoparticle. But the synthetic 
control is a very challenger for preparing a targeted polymeric nanoparticle in 
order to maintain the reproducibility of the nanoparticulate properties and its 
efficiency in the cancer treatment. Thus, there is much to be studied about the 
synthetic particularities of the polymeric nanoparticulate formulation for greater 
clinical application in the cancer treatment by PDT. In this sense, the development 
of nanoparticulate systems consistently involves a lot of work to study the several 
variables and its synergistic or antagonistic combinations that influence the prop-
erties of nanoparticulate formulations. Besides, the decrease of the entrapment 
efficiency of the photosensitizer associated to decrease of the nanoparticle size, 
the influence of combinatory effect of the photobleaching of encapsulated pho-
tosensitizer and the aggregation state of the compound into the nanoparticle, the 
establishment of adequate loading of photosensitizer into the nanoparticle and the 
uptake of the polymeric nanoparticle into the disease cells should be considered to 
development nanoparticulate formulation with high photodynamic efficiency to 
reduce the viability of the cancer cells.
6. Conclusions
In this chapter we demonstrate the most significant parameters in decreasing the 
nanoparticles size were the increase in stirring rate and PVA concentration. Other 
factors that also reduced the particles size were the increase in the ethanol percent-
age in the aqueous phase and in the organic phase, and the increase in the photo-
sensitizer mass/polymer mass ratio. Nanoparticles prepared by the EDM showed 
smaller sizes than the nanoparticles prepared by the EEM but are less stable. The 
aqueous phase temperature showed double behavior in relation to the nanoparticles 
size, increasing or decreasing the size depending on the method used to prepare the 
nanoparticle. The other properties evaluated, such as zeta potential, entrapment 
and recovery efficiencies, residual PVA and residual chloroform, are dependent on 
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the size of the nanoparticle. Therefore, parameters that are significant in relation 
to size will also influence these properties. Properties as zeta potential, residual 
PVA and entrapment efficiency presented an inversely proportional relation with 
nanoparticle size while the recovery efficiency and residual chloroform were 
directly proportional. In most of the properties some significant binary effects were 
observed, but their influence was not predominant in the results.
Besides the parameters used in the nanoparticle preparation, the physicochemi-
cal properties of the photosensitizer can interfere on the entrapment efficiency, 
as well as the washing step of the nanoparticulate formulation can influence the 
residual PVA and the recovery efficiency. The short storage period of the nanopar-
ticulate formulation can affect the characteristics of the particle, favoring the 
nanoparticle aggregation in different temperature.
We have shown that the encapsulation of photosensitizers reduces the photo-
bleaching effect due to light scattering caused by the polymeric matrix, however 
more soluble photosensitizers even encapsulated can suffer photobleaching 
according to the laser power and irradiation dose used in the experiment, limit-
ing their ability to be used in PDT. The aggregation of the photosensitizer also 
causes a reduction in its photodynamic efficiency because it reduces the singlet 
oxygen generation, but the encapsulation improves the photosensitizer efficiency 
since the entrapment can reduce the aggregation of the lipophilic compounds in 
aqueous medium.
The photocytotoxicity of encapsulated photosensitizers depends on the 
incubation time, the photosensitizer concentration and the laser power, as well 
as the uptake of photosensitizer into the cancer cells. Drug delivery systems have 
improving the efficiency of the phthalocyanines and porphyrins to reduce the 
cell viability. However, the generalization of the conclusions about preparation of 
nanoparticulate formulations and photooxidation conditions should be done care-
fully, each nanoparticulate formulation behaves in a characteristic way and should 
be treated singularly.
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